Actinium Pharmaceuticals Inc Cash Flow Reinvestment Rate
Actinium Pharmaceuticals Inc cash flow reinvestment rate. Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow Reinvestment Rate of 0.02x as of June 2022, reinvesting $540.00K (capex $270.00K plus investments $-270.00K) from operating cash flow of $27.92 Million. Explore Actinium Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Actinium Pharmaceuticals Inc (2010–2022)
Cash flow reinvestment rate of Actinium Pharmaceuticals Inc from 2010 to 2022. Historical reinvestment intensity for Actinium Pharmaceuticals Inc across 3 annual periods. Explore ATNM capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Actinium Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2010–2022)
Actinium Pharmaceuticals Inc cash flow reinvestment rate by year from 2010 to 2022. Year-by-year capital reinvestment analysis for Actinium Pharmaceuticals Inc. For the full cash flow conversion analysis, see Actinium Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $732.00K | $8.64 Million | $366.00K | — |
| 2011 | 0.00x | $0.00 | $539.00 | $0.00 | — |
| 2010 | 0.00x | $0.00 | $7.83K | $0.00 | — |